News Sentiment

CRVO sentiment intelligence

CervoMed Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.24 Week of 19 Jun 2026
Weighted tone 58/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 43

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+73.1% over one week, +38.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

CervoMed (NASDAQ: CRVO) seeks $10M via 2.5M-share offering; patent allowance noted

Market Reaction

Price moving ahead of tone

69/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction 73.1% Price confirming higher
Trend fit Trend inactive 38.6% over four weeks
Fair value -54.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 19
Neutral 29
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 43
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 15
TradingView 7
Market source 7
Investing.com 3
GlobeNewswire 2
Moomoo 2
StocksToTrade 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 8
Balance sheet 6
Deals and strategy 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-50 of 50
Investing.com India Direct company coverage

CervoMed director Joshua Boger acquires $2.99m in common stock By Investing.com

CervoMed director Joshua Boger acquired common stock valued at nearly $3 million on June 11, 2026, as part of a private placement. This transaction increased his indirect holdings to 1,795,865 shares through trusts, in addition to his direct holdings. The company recently complet

Tone
Positive 70/100
Event
Market update
Published
16 Jun 2026 04:08
Source
Investing.com India
Stock Titan Direct company coverage

CervoMed (CRVO) major holder Boger discloses 19.99% ownership stake

Joshua S. Boger has filed an Amendment No. 2 to his Schedule 13D for CervoMed Inc. (CRVO), disclosing beneficial ownership of 2,204,143 shares, representing 19.99% of the outstanding common stock. This ownership includes direct holdings, shares held in trusts, stock options, and

Tone
Neutral 50/100
Event
Deals and strategy
Published
16 Jun 2026 04:08
Source
Stock Titan
Minichart Direct company coverage

CervoMed Inc. Files Form 8-K with SEC – Company Information, Address, and Common Stock Details

CervoMed Inc. has filed an 8-K form with the SEC on June 15, 2026, providing routine updates under Regulation FD, which ensures simultaneous access to material information for all investors. The filing includes details about the company's address, stock symbol (CRVO on NASDAQ), a

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 02:08
Source
Minichart
www.marketscreener.com Direct company coverage

Cervomed Insider Bought Shares Worth $3,000,000, According to a Recent SEC Filing

An insider at CervoMed Inc. recently purchased shares valued at $3,000,000, according to a recent SEC filing. This transaction was published on June 15, 2026, at 05:44 pm EDT. CervoMed Inc. is a clinical-stage biotechnology company focused on developing treatments for age-related

Tone
Positive 72/100
Event
Market update
Published
15 Jun 2026 22:08
Source
www.marketscreener.com
Stock Titan Direct company coverage

Boger family trusts boost CervoMed (CRVO) stake with 955K-unit private deal

Trusts linked to CervoMed director Joshua S. Boger significantly increased their indirect stake in the company through a private placement. The Joshua S. Boger 2021 Trust acquired 955,414 units, each comprising one common share, a Series B warrant, and a Series C warrant, for $3.

Tone
Positive 73/100
Event
Deals and strategy
Published
15 Jun 2026 21:08
Source
Stock Titan